SK287762B6 - Použitie aplidínu na prípravu farmaceutického prostriedku na liečenie rakoviny - Google Patents

Použitie aplidínu na prípravu farmaceutického prostriedku na liečenie rakoviny Download PDF

Info

Publication number
SK287762B6
SK287762B6 SK659-2002A SK6592002A SK287762B6 SK 287762 B6 SK287762 B6 SK 287762B6 SK 6592002 A SK6592002 A SK 6592002A SK 287762 B6 SK287762 B6 SK 287762B6
Authority
SK
Slovakia
Prior art keywords
aplidine
patients
weeks
dose
infusion
Prior art date
Application number
SK659-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK6592002A3 (en
Inventor
Glynn Thomas Faircloth
Chris Twelves
Luis Paz-Ares
Original Assignee
Pharma Mar, S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9927006.8A external-priority patent/GB9927006D0/en
Priority claimed from GB0005701A external-priority patent/GB0005701D0/en
Priority claimed from GB0007639A external-priority patent/GB0007639D0/en
Priority claimed from GB0015496A external-priority patent/GB0015496D0/en
Priority claimed from GB0025209A external-priority patent/GB0025209D0/en
Application filed by Pharma Mar, S. A. filed Critical Pharma Mar, S. A.
Publication of SK6592002A3 publication Critical patent/SK6592002A3/sk
Publication of SK287762B6 publication Critical patent/SK287762B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SK659-2002A 1999-11-15 2000-11-15 Použitie aplidínu na prípravu farmaceutického prostriedku na liečenie rakoviny SK287762B6 (sk)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GBGB9927006.8A GB9927006D0 (en) 1999-11-15 1999-11-15 Aplidine treatment of cancers
GB0005701A GB0005701D0 (en) 2000-03-09 2000-03-09 Antitumor utility of aplidine
GB0007639A GB0007639D0 (en) 2000-03-29 2000-03-29 Antitumour and anti-angiogenic compound
GB0015496A GB0015496D0 (en) 2000-06-23 2000-06-23 Antitumour and anti-angiogenic compound
GB0025209A GB0025209D0 (en) 2000-10-13 2000-10-13 Treatment of cancers
PCT/GB2000/004349 WO2001035974A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers

Publications (2)

Publication Number Publication Date
SK6592002A3 SK6592002A3 (en) 2003-08-05
SK287762B6 true SK287762B6 (sk) 2011-09-05

Family

ID=27515929

Family Applications (1)

Application Number Title Priority Date Filing Date
SK659-2002A SK287762B6 (sk) 1999-11-15 2000-11-15 Použitie aplidínu na prípravu farmaceutického prostriedku na liečenie rakoviny

Country Status (27)

Country Link
US (1) US20090298752A1 (zh)
EP (1) EP1229922B1 (zh)
JP (1) JP2003514025A (zh)
KR (1) KR100518986B1 (zh)
CN (1) CN1423564A (zh)
AT (1) ATE363910T1 (zh)
AU (1) AU780417B2 (zh)
BG (1) BG65381B1 (zh)
BR (1) BR0015811A (zh)
CA (1) CA2391502A1 (zh)
CY (1) CY1106825T1 (zh)
CZ (1) CZ302498B6 (zh)
DE (1) DE60035120T2 (zh)
DK (1) DK1229922T3 (zh)
ES (1) ES2288486T3 (zh)
HK (1) HK1045648B (zh)
HU (1) HUP0203906A2 (zh)
IL (1) IL149488A0 (zh)
MX (1) MXPA02004862A (zh)
NO (1) NO330719B1 (zh)
NZ (1) NZ518847A (zh)
PL (1) PL200922B1 (zh)
PT (1) PT1229922E (zh)
RU (1) RU2261104C2 (zh)
SI (1) SI1229922T1 (zh)
SK (1) SK287762B6 (zh)
WO (1) WO2001035974A2 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030148933A1 (en) 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB9803448D0 (en) 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
US7507766B2 (en) 2000-10-12 2009-03-24 Pharma Mar, S.A. Treatment of cancers
EP1435991B1 (en) * 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
PL1603584T3 (pl) * 2003-03-12 2009-02-27 Dana Farber Cancer Inst Inc Aplidyna do leczenia szpiczaka mnogiego
EP1620117A4 (en) * 2003-03-12 2009-07-29 Pharma Mar Sa IMPROVED ANTITUMORAL TREATMENTS
EP2029155B1 (en) 2006-02-28 2016-04-13 Pharma Mar S.A. Improved treatment of multiple myeloma
WO2008052931A1 (en) * 2006-11-03 2008-05-08 Nerviano Medical Sciences S.R.L. A method of administering an antitumor compound
EP2205263A1 (en) * 2007-10-19 2010-07-14 Pharma Mar, S.A. Improved antitumoral treatments
MX2010009697A (es) * 2008-03-07 2010-09-30 Pharm Mar S A Tratamientos anticancerigenos mejorados.
CN103463020B (zh) * 2013-09-23 2015-11-25 李淑兰 Lycojaponicumin A在制备治疗肾癌药物中的应用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342744A (en) * 1979-07-19 1982-08-03 Lever Brothers Company Hair treatment products
US4950649A (en) * 1980-09-12 1990-08-21 University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
EP0048149B1 (en) * 1980-09-12 1983-11-30 University of Illinois Foundation Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
ATE74761T1 (de) * 1985-09-20 1992-05-15 Cernitin Sa Verwendung von pflanzenpollenextrakten zur herstellung von das wachstum von tumorzellen hemmenden pharmazeutischen praeparaten und verfahren zu ihrer herstellung.
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US5580871A (en) * 1992-11-20 1996-12-03 The Dupont Merck Pharmaceutical Company 4-Heteroaryl- 1,4-dihydropyridine compounds with calcium agonist and alpha1 -antagonist activity
FR2698543B1 (fr) * 1992-12-02 1994-12-30 Rhone Poulenc Rorer Sa Nouvelles compositions à base de taxoides.
US5462726A (en) * 1993-12-17 1995-10-31 Bristol-Myers Squibb Company Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
AU681231B2 (en) * 1993-12-29 1997-08-21 Intarcia Therapeutics, Inc. Methods and compositions for the treatment of a host with a cellular proliferative disease
US5861439A (en) * 1994-11-14 1999-01-19 Alza Corporation Method for enhanced electrotransport agent delivery
US6365597B1 (en) * 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
JP4172726B2 (ja) * 1996-05-22 2008-10-29 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤
US6156724A (en) * 1996-06-07 2000-12-05 Rinehart; Kenneth L. Uses of didemnins as immunomodulating agents
US6034058A (en) * 1997-04-15 2000-03-07 Rinehart; Kenneth L. Semi-synthetic alanyl dilemnin analogs
CA2288639A1 (en) * 1997-05-07 1998-11-12 Pharma Mar, S.A. Aplidine as an l-type calcium channel enhancer
US6245759B1 (en) * 1999-03-11 2001-06-12 Merck & Co., Inc. Tyrosine kinase inhibitors
US20010021380A1 (en) * 1999-04-19 2001-09-13 Pluenneke John D. Soluble tumor necrosis factor receptor treatment of medical disorders
US6890904B1 (en) * 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
IL152111A0 (en) * 2000-04-07 2003-07-31 Univ Pennsylvania Tamandarin and didemnin analogs and methods of making and using them
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
AU2002213053B2 (en) * 2000-10-05 2006-12-21 Immunex Corporation Nectin polypeptides, polynucleotides, methods of making and use thereof
US7507766B2 (en) * 2000-10-12 2009-03-24 Pharma Mar, S.A. Treatment of cancers
WO2002032374A2 (en) * 2000-10-18 2002-04-25 Immunex Corporation Methods for treating il-18 mediated disorders
US6610399B1 (en) * 2000-11-17 2003-08-26 Structural Technologies, Llc Multi-layer, thermal protection and corrosion protection coating system for metallic tendons, especially for external post-tensioning systems
EP1435991B1 (en) * 2001-10-19 2008-10-15 Pharma Mar, S.A. Use of aplidine for the treatment of pancreatic cancer
PL1603584T3 (pl) * 2003-03-12 2009-02-27 Dana Farber Cancer Inst Inc Aplidyna do leczenia szpiczaka mnogiego
EP1620117A4 (en) * 2003-03-12 2009-07-29 Pharma Mar Sa IMPROVED ANTITUMORAL TREATMENTS
AU2004224418A1 (en) * 2003-03-21 2004-10-07 Madeleine M. Joullie Tamandarin analogs and fragments thereof and methods of making and using
KR20060031809A (ko) * 2003-06-09 2006-04-13 더 리젠츠 오브 더 유니버시티 오브 미시간 암 치료 및 진단용 조성물 및 방법
EP2029155B1 (en) * 2006-02-28 2016-04-13 Pharma Mar S.A. Improved treatment of multiple myeloma
EP2205263A1 (en) * 2007-10-19 2010-07-14 Pharma Mar, S.A. Improved antitumoral treatments

Also Published As

Publication number Publication date
CZ302498B6 (cs) 2011-06-15
CY1106825T1 (el) 2012-05-23
CN1423564A (zh) 2003-06-11
PT1229922E (pt) 2007-09-12
WO2001035974A3 (en) 2001-11-01
EP1229922B1 (en) 2007-06-06
EP1229922A2 (en) 2002-08-14
WO2001035974A2 (en) 2001-05-25
NO330719B1 (no) 2011-06-20
KR20020064313A (ko) 2002-08-07
NO20022293L (no) 2002-07-05
NZ518847A (en) 2004-02-27
DE60035120D1 (de) 2007-07-19
PL200922B1 (pl) 2009-02-27
CA2391502A1 (en) 2001-05-25
US20090298752A1 (en) 2009-12-03
DK1229922T3 (da) 2007-10-08
DE60035120T2 (de) 2008-01-31
CZ20021697A3 (cs) 2003-02-12
RU2002115864A (ru) 2004-01-20
AU780417B2 (en) 2005-03-17
BG106714A (en) 2003-02-28
NO20022293D0 (no) 2002-05-14
SK6592002A3 (en) 2003-08-05
KR100518986B1 (ko) 2005-10-06
BG65381B1 (bg) 2008-05-30
ATE363910T1 (de) 2007-06-15
SI1229922T1 (sl) 2008-04-30
BR0015811A (pt) 2002-08-06
HK1045648A1 (en) 2002-12-06
JP2003514025A (ja) 2003-04-15
HK1045648B (zh) 2007-09-21
ES2288486T3 (es) 2008-01-16
PL355335A1 (en) 2004-04-19
MXPA02004862A (es) 2003-01-28
AU1402301A (en) 2001-05-30
IL149488A0 (en) 2002-11-10
RU2261104C2 (ru) 2005-09-27
HUP0203906A2 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
US20090298752A1 (en) Aplidine treatment of cancers
KR100718946B1 (ko) 효과적인 항종양 치료
RU2306933C2 (ru) Улучшенная схема применения противоопухолевого соединения в терапии рака
JP2010031043A (ja) ガンの治療
CZ20014081A3 (cs) Prostředky a pouľití ET743 pro léčení rakoviny
JP2009536956A (ja) 抗癌治療法
AU2001294024B2 (en) Treatment of cancers by aplidine in conjunction with a myoprotector
US6541509B2 (en) Method for treating neoplasia using combination chemotherapy
AU2001294024A1 (en) Treatment of cancers by aplidine in conjunction with a myoprotector
UA78186C2 (en) Use of aplidine for treatment of malignant tumours
ZA200302738B (en) Treatment of cancers by aplidine in conjuction with a myoprotector.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20110711